Walter Woltosz Sells 4,177 Shares of Simulations Plus (NASDAQ:SLP) Stock

Simulations Plus, Inc. (NASDAQ:SLP) Director Walter Woltosz sold 4,177 shares of the stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $18.44, for a total value of $77,023.88. Following the transaction, the director directly owned 3,202,131 shares of the company’s stock, valued at $59,047,295.64. The trade was a 0.13% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Simulations Plus Price Performance

Shares of NASDAQ:SLP opened at $18.28 on Wednesday. Simulations Plus, Inc. has a 1 year low of $11.09 and a 1 year high of $21.01. The firm has a market capitalization of $369.26 million, a PE ratio of -5.84 and a beta of 1.30. The business’s 50 day moving average price is $16.32 and its 200-day moving average price is $15.48.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating analysts’ consensus estimates of $0.27 by $0.08. Simulations Plus had a positive return on equity of 16.21% and a negative net margin of 77.96%.The company had revenue of $24.29 million for the quarter, compared to analyst estimates of $21.66 million. As a group, analysts expect that Simulations Plus, Inc. will post 0.8 earnings per share for the current year.

Analyst Ratings Changes

Several analysts recently issued reports on the stock. Craig Hallum cut shares of Simulations Plus from a “buy” rating to a “hold” rating and set a $18.50 price objective for the company. in a research note on Thursday, June 18th. Wall Street Zen cut Simulations Plus from a “buy” rating to a “hold” rating in a report on Saturday, June 13th. TD Cowen dropped their price target on Simulations Plus from $19.00 to $16.00 and set a “hold” rating for the company in a research report on Friday, April 10th. Weiss Ratings upgraded Simulations Plus from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, June 5th. Finally, William Blair lowered Simulations Plus from an “outperform” rating to a “market perform” rating in a research note on Wednesday, June 17th. One investment analyst has rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, Simulations Plus currently has an average rating of “Hold” and an average target price of $19.88.

Institutional Trading of Simulations Plus

Several hedge funds have recently made changes to their positions in the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Simulations Plus by 4.3% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,493 shares of the technology company’s stock valued at $233,000 after acquiring an additional 390 shares during the last quarter. GAMMA Investing LLC raised its position in Simulations Plus by 26.0% in the second quarter. GAMMA Investing LLC now owns 2,831 shares of the technology company’s stock valued at $52,000 after purchasing an additional 585 shares during the period. Bank of New York Mellon Corp raised its position in Simulations Plus by 1.3% in the first quarter. Bank of New York Mellon Corp now owns 63,592 shares of the technology company’s stock valued at $752,000 after purchasing an additional 844 shares during the period. Deutsche Bank AG lifted its stake in shares of Simulations Plus by 5.9% in the 4th quarter. Deutsche Bank AG now owns 15,825 shares of the technology company’s stock valued at $288,000 after purchasing an additional 875 shares during the last quarter. Finally, Prudential Financial Inc. grew its holdings in shares of Simulations Plus by 5.7% during the 2nd quarter. Prudential Financial Inc. now owns 17,213 shares of the technology company’s stock worth $300,000 after purchasing an additional 930 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

About Simulations Plus

Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company’s flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.